1. Repressor activator protein 1–promoted colorectal cell migration is associated with the regulation of Vimentin
   Yongyong Yang et al, 2017, Tumor Biology CrossRef
2. Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells
   Nobuo Watanabe et al, 2020, Cancer Cell International CrossRef
3. Advances in the Theranostics of Oesophageal Squamous Carcinoma
   Miaomiao Cheng et al, 2023, Advanced Therapeutics CrossRef
4. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma
   Yoichiro IKOMA et al, 2015, Biomedical Research CrossRef
5. Expression of Podoplanin in Sinonasal Squamous Cell Carcinoma and Its Clinical Significance
   Huan Wang et al, 2020, American Journal of Rhinology & Allergy CrossRef
6. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review
   Chunni Wang et al, 2017, Chinese Journal of Cancer CrossRef
7. Roles of Podoplanin in Malignant Progression of Tumor
   Hiroyuki Suzuki et al, 2022, Cells CrossRef
8. Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
   Pengjun Zhou et al, 2017, Oncotarget CrossRef
9. Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
   Jia xi Yao et al, 2020, Frontiers in Oncology CrossRef
10. Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
    Guanjie Li et al, 2022, Antibodies CrossRef
11. Development of a Novel Anti−CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas
    Nohara Goto et al, 2022, International Journal of Molecular Sciences CrossRef
12. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment
    JI YOON LEE et al, 2016, Molecular Medicine Reports CrossRef
13. Wnt3a expression is associated with poor prognosis of esophageal squamous cell carcinoma
    Junya Oguma et al, 2017, Oncology Letters CrossRef
14. A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction
    Nobuo Watanabe et al, 2019, PLOS ONE CrossRef
15. Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI
    Nobuo Watanabe et al, 2024, Thrombosis and Haemostasis CrossRef
16. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis
    Liya Hu et al, 2020, BMC Cancer CrossRef
17. Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors
    Duygu Gülseren et al, 2020, Journal of Histotechnology CrossRef
18. Platelets involved tumor cell EMT during circulation: communications and interventions
    Xiaoying Wang et al, 2022, Cell Communication and Signaling CrossRef
19. Podoplanin and SOX2 Expression in CIN 3–like Squamous Cell Carcinoma of the Cervix
    Colin J.R. Stewart et al, 2018, International Journal of Gynecological Pathology CrossRef
20. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
    Ute Warnecke-Eberz et al, 2020, World Journal of Gastroenterology CrossRef
21. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma
    Woo-Young Sun et al, 2016, Tumor Biology CrossRef
22. Prognostic Value of Podoplanin in Various Tumors
    Xiaohang Wang et al, 2021, Technology in Cancer Research & Treatment CrossRef
23. Phosphorylation of ETS‐1 is a critical event in DNA polymerase iota‐induced invasion and metastasis of esophageal squamous cell carcinoma
    Chao He et al, 2017, Cancer Science CrossRef